Q1 2024 IP Activity Reveals Growth and Litigation in Key mRNA Market
SOPHIA ANTIPOLIS, France – April 18, 2024 │ The quarterly report for the Q1 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. What’s new this quarter? Q1 2024 IP Activity overview The IP activity during Q1 2024 follow 2023’s[…]